Metropolitan Life Insurance Company (MetLife)’s Ares Management ARES Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-8,647
Closed -$703K 2272
2021
Q4
$703K Buy
8,647
+213
+3% +$17.3K 0.01% 1201
2021
Q3
$623K Sell
8,434
-280
-3% -$20.2K 0.01% 1302
2021
Q2
$554K Buy
8,714
+1,586
+22% +$88.7K 0.01% 1462
2021
Q1
$399K Sell
7,128
-321
-4% -$16.1K 0.01% 1555
2020
Q4
$350K Sell
7,449
-145
-2% -$6.56K 0.01% 1596
2020
Q3
$307K Sell
7,594
-197
-3% -$7.87K 0.01% 1524
2020
Q2
$309K Sell
7,791
-14,277
-65% -$504K 0.01% 1525
2020
Q1
$683K Buy
22,068
+454
+2% +$15.9K 0.01% 881
2019
Q4
$771K Sell
21,614
-490
-2% -$15.2K 0.01% 1062
2019
Q3
$593K Buy
22,104
+17,283
+358% +$494K 0.01% 1190
2019
Q2
$126K Buy
+4,821
New +$122K ﹤0.01% 2189

Other funds holding ARES

Metropolitan Life Insurance Company (MetLife)'s ARES Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Ares Management (ARES) in Q1 2022, closing a stake of 8,647 shares — an estimated $703K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ARES in Q2 2019 and held it in 11 quarters. The position peaked at $771K in Q4 2019. 366 funds tracked by Wall St. Rank hold ARES as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Ares Management position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 8,647 Ares Management shares in Q1 2022, an estimated $703K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Ares Management in Q2 2019 and held it in 11 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Ares Management position peaked at $771K in Q4 2019.
  • 366 funds tracked by Wall St. Rank held Ares Management as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.